Producer
Merck KGaA (MilliporeSigma / SAFC Biosciences)
Merck KGaA (Darmstadt; family-owned since 1668; Life Science division ~$9B revenue) produces CHO cell culture media through its MilliporeSigma brand in North America and SAFC (Sigma-Aldrich Formulation & Custom manufacturing) globally. SAFC Biosciences is the custom media manufacturing arm that produces proprietary 'black box' formulations for major biopharmaceutical companies under NDA — meaning a significant fraction of industry media demand is manufactured exclusively by Merck KGaA under confidential contracts. Merck KGaA's media manufacturing sites include St. Louis, Missouri (Sigma-Aldrich legacy site) and Martillac, France (custom bioscience manufacturing). The same Merck KGaA Darmstadt organization manufactures EUV photoresists (display and semiconductor), liquid crystals for flat panels, and Fractogel chromatography resins — a German family-controlled conglomerate touching monoclonal antibody media, display materials, and semiconductor chemicals from one Hessen campus.
2
Inputs supplied
2
Goods downstream
2
Facilities
0
Stories
What they make
2 inputs Merck KGaA (MilliporeSigma / SAFC Biosciences) supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Merck KGaA (MilliporeSigma / SAFC Biosciences) makes, pick one to see the full supply chain.
Where they make it
2 facilities
Merck KGaA / SAFC Biosciences (St. Louis, MO) →
USMissouri · manufacturing
Merck KGaA / MilliporeSigma / SAFC Biosciences St. Louis MO — legacy Sigma-Aldrich campus and primary North American SAFC custom and standard media manufacturing site. SAFC (Sigma-Aldrich Fine Chemicals / SAFC Biosciences) produces proprietary and custom CHO cell culture media under NDA for major biopharmaceutical companies. Sigma-Aldrich was acquired by Merck KGaA for $17B in 2015. Source: https://www.sigmaaldrich.com/US/en/applications/cell-culture-applications
MilliporeSigma Jaffrey Manufacturing →
USNew Hampshire · filter_manufacturing
Primary US Durapore PVDF membrane production; FDA-validated GMP filter manufacture; industry-standard 0.22-μm filter for ophthalmic aseptic fill
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
Life Science (MilliporeSigma / SAFC)
45%Electronics (Liquid Crystals + Semiconductor)
25%Healthcare Pharma (Biopharma + Oncology)
30%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Did you know2023
Merck KGaA (Darmstadt; family-owned since 1668) manufactures CHO cell culture media through SAFC Biosciences while simultaneously being the world's dominant producer of EUV photoresists (SEMI industry: >90% market share in EUV ArF photoresists under the EMD Electronics brand) and liquid crystal materials for flat panel displays (~25% global market via Merck Display Technologies). The same Darmstadt chemistry organization that formulates proprietary cell culture media for biopharmaceutical companies under NDA also formulates the photosensitive polymer layers that ASML EUV machines pattern onto silicon wafers. A single German family-controlled company — without a US headquarters, traded on the Frankfurt Stock Exchange — holds dominant market positions in cell culture media (critical to every biologic drug), EUV photoresists (critical to every advanced chip), and liquid crystal materials (critical to every LCD display). Merck KGaA's combined supply chain significance is greater than any single-sector analysis reveals. US supply chain policy frameworks analyze pharmaceutical supply chains, semiconductor supply chains, and electronics supply chains in separate silos — none captures that Merck KGaA is a critical chokepoint in all three simultaneously.
Merck KGaA ↗Origin2023
Merck KGaA claims to be the world's oldest operating pharmaceutical/chemical company, with unbroken operation since 1668 — when Friedrich Jacob Merck purchased the Engel-Apotheke (Angel Pharmacy) in Darmstadt, Germany. The company predates: the United States (1776), the French Revolution (1789), the steam engine (1769), and modern chemistry (Lavoisier's 1789 oxygen theory). The Merck family has maintained majority control through 11 generations since 1668. When Merck went public in 1995, the family retained ~70% through an unusual structure: the Merck KGaA listed on the Frankfurt Stock Exchange but with the Merck family holding majority via a partnership stake — preventing any hostile takeover of a 355+ year family enterprise. The American company Merck & Co. (now MSD in most non-US markets) is a different company: it was originally established as the US subsidiary of Merck KGaA in 1891, was confiscated as enemy property during World War I (1917), and became an independent US company. The German Merck KGaA and US Merck & Co. have been separate companies for over 100 years but share the same historical origin.
Merck KGaA ↗